- HK$1.52bn
- HK$620.38m
- CNY768.90m
- 61
- 91
- 74
- 90
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.36 | ||
| Price to Tang. Book | 0.62 | ||
| Price to Free Cashflow | 5.85 | ||
| Price to Sales | 1.87 | ||
| EV to EBITDA | 2.05 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 3.6% | ||
| Return on Equity | 3.76% | ||
| Operating Margin | 23.34% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 247.35 | 271.4 | 536.83 | 675.08 | 768.9 | n/a | n/a | 16.25% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +463.52 | -55.77 | -60.13 | +38.32 | -3.48 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
PW Medtech Group Ltd is a company principally engaged in the research and development (R&D) and sales of medical devices. The Company operates its businesses through three segments. Infusion Set Business segment is mainly engaged in the R&D, manufacturing and sales of advanced infusion set, intravenous cannula products, insulin needles. Blood Purification Business segment is mainly involved in the R&D, manufacturing and sales of hemodialysis and blood purification medical devices. Regenerative Medical Biomaterials Business segment is mainly involved in the R&D and manufacturing of animal-derived tissue regenerative medical biomaterials and human tissue repair alternative product. The Company mainly operates its businesses in the domestic market.
Directors
- Yue'e Zhang CHM (57)
- Jie Wang CFO (41)
- Yikun Chen VPR (38)
- Wei Hua VPR (44)
- Tin Yu Wong SEC
- Liwei Jiang NED (51)
- Junshan Lin NED (52)
- Geng Chen NID (44)
- Fengli Wang NID (58)
- Xiaogang Wang NID (41)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- May 13th, 2011
- Public Since
- November 8th, 2013
- No. of Employees
- 1,415
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Stock Exchange of Hong Kong Limited- Shares in Issue
- 1,533,231,098
- Address
- Level 54, BEIJING, 101204
- Web
- https://www.pwmedtech.com/
- Phone
- +86 1084783617
- Auditors
- BDO LTD
Upcoming Events for 1358
PW Medtech Group Ltd Annual Shareholders Meeting
Dividend For 1358.HK - 0.0530 HKD
Similar to 1358
Acotec Scientific Holdings
Stock Exchange of Hong Kong Limited
Beijing Airdoc Technology Co
Stock Exchange of Hong Kong Limited
AK Medical Holdings
Stock Exchange of Hong Kong Limited
AMCO United Holding
Stock Exchange of Hong Kong Limited
Angelalign Technology
Stock Exchange of Hong Kong Limited
FAQ
What is the PW Medtech share price?
As of Today at 22:47 UTC, shares in PW Medtech are trading at HK$1.00. This share price information is delayed by 15 minutes.
How has the PW Medtech share price performed this year?
Shares in PW Medtech last closed at HK$1.00 and the price had moved by +5.26% over the past 365 days. In terms of relative price strength the PW Medtech share price has outperformed the FTSE Developed Asia Pacific Index by +6.47% over the past year.
What are the analyst and broker recommendations for PW Medtech?
The overall consensus recommendation for PW Medtech is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the PW Medtech dividend yield?
The PW Medtech dividend yield is 9.8% based on the trailing twelve month period.
Does PW Medtech pay a dividend?
Last year, PW Medtech paid a total dividend of CNY0.09, and it currently has a trailing dividend yield of 9.8%.Looking ahead, shares in PW Medtech are due to go ex-dividend on 2025-07-03 and the next dividend pay date is 2025-07-25.
When does PW Medtech next pay dividends?
PW Medtech are due to go ex-dividend on 2025-07-03 and the next dividend pay date is 2025-07-25. The historic dividend yield on PW Medtech shares is currently 9.8%.
How do I buy PW Medtech shares?
To buy shares in PW Medtech you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of PW Medtech?
As of the previous close price of HK$1.00, shares in PW Medtech had a market capitalisation of HK$1.52bn.
Where are PW Medtech shares listed?
Here are the trading details for PW Medtech:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 1358
What kind of share is PW Medtech?
Based on an overall assessment of its quality, value and momentum PW Medtech is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a PW Medtech share price forecast for 2025?
The analyst consensus target price for shares in PW Medtech is HK$2.22. That is 121.87% above the last closing price of HK$1.00.
Analysts covering PW Medtech currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreWhat is the trend in the PW Medtech share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like PW Medtech. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -0.97%.
As of the last closing price of HK$1.00, shares in PW Medtech were trading -4.06% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the PW Medtech PE Ratio?
The PW Medtech PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$1.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of PW Medtech?
PW Medtech's management team is headed by:
- Yue'e Zhang - CHM
- Jie Wang - CFO
- Yikun Chen - VPR
- Wei Hua - VPR
- Tin Yu Wong - SEC
- Liwei Jiang - NED
- Junshan Lin - NED
- Geng Chen - NID
- Fengli Wang - NID
- Xiaogang Wang - NID